ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

NCI Budget 6% Below 1980 Level; Prevention, Groups, Lost Most

February 8, 1991

Marc Lippman To Leave Georgetown For Michigan To Head Internal Medicine; Five Named To DCLG.

September 15, 2000

NCA Okays Only A committee For Centers, Not New Division

May 29, 1987

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997